S.M. Peña

646 total citations
11 papers, 170 citations indexed

About

S.M. Peña is a scholar working on Epidemiology, Dermatology and Pharmacology. According to data from OpenAlex, S.M. Peña has authored 11 papers receiving a total of 170 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 4 papers in Dermatology and 2 papers in Pharmacology. Recurrent topics in S.M. Peña's work include Nail Diseases and Treatments (3 papers), Dermatology and Skin Diseases (3 papers) and Pneumonia and Respiratory Infections (2 papers). S.M. Peña is often cited by papers focused on Nail Diseases and Treatments (3 papers), Dermatology and Skin Diseases (3 papers) and Pneumonia and Respiratory Infections (2 papers). S.M. Peña collaborates with scholars based in United States, Italy and South Korea. S.M. Peña's co-authors include Victoria P. Werth, Majid Zeidi, Hee Joo Kim, Diletta Bonciani, Boni E. Elewski, Nancy Dgetluck, Joyce Okawa, S. Constantine, Barbara White and Naomi Lawrence and has published in prestigious journals such as PLoS ONE, Annals of the Rheumatic Diseases and Journal of Investigative Dermatology.

In The Last Decade

S.M. Peña

11 papers receiving 169 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S.M. Peña United States 6 75 67 58 32 23 11 170
Valérie Callot France 6 48 0.6× 116 1.7× 72 1.2× 56 1.8× 11 0.5× 6 220
J. Natkunarajah United Kingdom 8 32 0.4× 66 1.0× 47 0.8× 65 2.0× 12 0.5× 26 179
Jameleddine Zili Tunisia 9 45 0.6× 133 2.0× 32 0.6× 79 2.5× 10 0.4× 55 230
Á. Zulaica Spain 11 60 0.8× 119 1.8× 15 0.3× 22 0.7× 31 1.3× 31 244
Temitayo Ogunleye United States 8 64 0.9× 112 1.7× 28 0.5× 8 0.3× 10 0.4× 25 207
José Mesquita‐Guimarães Portugal 8 30 0.4× 138 2.1× 62 1.1× 77 2.4× 15 0.7× 18 235
Junko Sowa Japan 10 38 0.5× 110 1.6× 14 0.2× 12 0.4× 12 0.5× 30 190
Nicola Milanesi Italy 8 22 0.3× 114 1.7× 16 0.3× 11 0.3× 6 0.3× 27 136
Hilal Kaya Erdoğan Türkiye 9 31 0.4× 140 2.1× 37 0.6× 4 0.1× 25 1.1× 51 253
Victor Georgescu France 11 21 0.3× 208 3.1× 22 0.4× 9 0.3× 21 0.9× 19 286

Countries citing papers authored by S.M. Peña

Since Specialization
Citations

This map shows the geographic impact of S.M. Peña's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S.M. Peña with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S.M. Peña more than expected).

Fields of papers citing papers by S.M. Peña

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S.M. Peña. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S.M. Peña. The network helps show where S.M. Peña may publish in the future.

Co-authorship network of co-authors of S.M. Peña

This figure shows the co-authorship network connecting the top 25 collaborators of S.M. Peña. A scholar is included among the top collaborators of S.M. Peña based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S.M. Peña. S.M. Peña is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Cole, Matthew, Karen Edge, Kathy Kudish, et al.. (2024). Differences in Pertussis Incidence by Race and Ethnicity in the United States, 2010–2017. Open Forum Infectious Diseases. 11(4). ofae177–ofae177. 2 indexed citations
2.
McNamara, Lucy A., Lucia C. Pawloski, Elizabeth C. Briere, et al.. (2023). High post-exposure prophylaxis (PEP) uptake among household contacts of pertussis patients enrolled in a PEP effectiveness evaluation – United States, 2015–2017. PLoS ONE. 18(5). e0285953–e0285953. 1 indexed citations
3.
Werth, Victoria P., S.M. Peña, Majid Zeidi, et al.. (2022). Safety and Efficacy of Lenabasum, a Cannabinoid Receptor Type 2 Agonist, in Patients with Dermatomyositis with Refractory Skin Disease: A Randomized Clinical Trial. Journal of Investigative Dermatology. 142(10). 2651–2659.e1. 37 indexed citations
4.
Peña, S.M., et al.. (2022). Seborrheic Dermatitis in Older Adults: Pathogenesis and Treatment Options. Drugs & Aging. 39(5). 315–321. 15 indexed citations
5.
Peña, S.M., et al.. (2020). Topical crisaborole is an efficacious steroid‐sparing agent for treating mild‐to‐moderate seborrhoeic dermatitis. Journal of the European Academy of Dermatology and Venereology. 34(12). e809–e812. 9 indexed citations
6.
Werth, V., S.M. Peña, Ruofei Feng, et al.. (2018). 605 Study of safety and efficacy of lenabasum, a cannabinoid receptor type 2 agonist, in refractory skin-predominant dermatomyositis. Journal of Investigative Dermatology. 138(5). S103–S103. 5 indexed citations
7.
Kim, Hee Joo, et al.. (2018). Itch in dermatomyositis: the role of increased skin interleukin-31. British Journal of Dermatology. 179(3). 669–678. 64 indexed citations
8.
Werth, Victoria P., S.M. Peña, Joyce Okawa, et al.. (2018). FRI0470 A phase 2 study of safety and efficacy of lenabasum (JBT-101), a cannabinoid receptor type 2 agonist, in refractory skin-predominant dermatomyositis. Annals of the Rheumatic Diseases. 77. 763–764. 16 indexed citations
9.
Peña, S.M. & Naomi Lawrence. (2017). Analysis of Wait Times and Impact of Real-Time Surveys on Patient Satisfaction. Dermatologic Surgery. 43(10). 1288–1291. 5 indexed citations
10.
Peña, S.M., Aimee Payne, John R. Stanley, & Victoria P. Werth. (2017). 389 Quality of Life in Autoimmune Blistering Diseases (AIBD). Journal of Investigative Dermatology. 137(5). S67–S67. 1 indexed citations
11.
Jiménez-Ruíz, Carlos A., et al.. (2013). Increasing the Dose of Varenicline in Patients Who Do Not Respond to the Standard Dose. Mayo Clinic Proceedings. 88(12). 1443–1445. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026